These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 11400186

  • 21. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
    Wendt T, van der Does R, Schräder R, Landgraf H, Kober G.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
    [Abstract] [Full Text] [Related]

  • 22. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J.
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [Abstract] [Full Text] [Related]

  • 23. Vasodilatory effects of carvedilol and pindolol.
    Sundberg S, Tiihonen K, Gordin A.
    J Cardiovasc Pharmacol; 1987 Jul; 10 Suppl 11():S76-80. PubMed ID: 2454373
    [Abstract] [Full Text] [Related]

  • 24. Alpha 1-blocking properties of carvedilol during acute and chronic administration.
    Giannattasio C, Cattaneo BM, Seravalle G, Carugo S, Mangoni AA, Grassi G, Zanchetti A, Mancia G.
    J Cardiovasc Pharmacol; 1992 Jul; 19 Suppl 1():S18-22. PubMed ID: 1378144
    [Abstract] [Full Text] [Related]

  • 25. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
    Hashimoto H, Kanda A, Hubo H, Tanaka M.
    J Cardiovasc Pharmacol; 1991 Jul; 18 Suppl 4():S22-8. PubMed ID: 1721975
    [Abstract] [Full Text] [Related]

  • 26. Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.
    Vittorio TJ, Zolty R, Kasper ME, Khandwalla RM, Hirsh DS, Tseng CH, Jorde UP, Ahuja K.
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):51-7. PubMed ID: 18287590
    [Abstract] [Full Text] [Related]

  • 27. Adrenergic blocker carvedilol attenuates the cardiovascular and aversive effects of nicotine in abstinent smokers.
    Sofuoglu M, Mouratidis M, Yoo S, Kosten T.
    Behav Pharmacol; 2006 Dec; 17(8):731-5. PubMed ID: 17110799
    [Abstract] [Full Text] [Related]

  • 28. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC, Nelson AH, Ohlstein EH, Willette RN, Sealey JE, Laragh JH, Campbell WG, Feuerstein GZ.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
    [Abstract] [Full Text] [Related]

  • 29. The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.
    Tham TC, Guy S, McDermott BJ, Shanks RG, Riddell JG.
    Br J Clin Pharmacol; 1995 Jul; 40(1):19-23. PubMed ID: 8527263
    [Abstract] [Full Text] [Related]

  • 30. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
    Dupont AG, Van der Niepen P, Taeymans Y, Ingels M, Piepsz A, Bossuyt AM, Block P, Six RO, Jonckheer MH, Vanhaelst L.
    J Cardiovasc Pharmacol; 1987 Jul; 10 Suppl 11():S130-6. PubMed ID: 2454359
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological characteristics of the stereoisomers of carvedilol.
    Bartsch W, Sponer G, Strein K, Müller-Beckmann B, Kling L, Böhm E, Martin U, Borbe HO.
    Eur J Clin Pharmacol; 1990 Jul; 38 Suppl 2():S104-7. PubMed ID: 1974497
    [Abstract] [Full Text] [Related]

  • 32. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
    Rouleau JL, Roecker EB, Tendera M, Mohacsi P, Krum H, Katus HA, Fowler MB, Coats AJ, Castaigne A, Scherhag A, Holcslaw TL, Packer M, Carvedilol Prospective Randomized Cumulative Survival Study Group.
    J Am Coll Cardiol; 2004 Apr 21; 43(8):1423-9. PubMed ID: 15093878
    [Abstract] [Full Text] [Related]

  • 33. Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects.
    Valentini M, Revera M, Bilo G, Caldara G, Savia G, Styczkiewicz K, Parati S, Gregorini F, Faini A, Branzi G, Malfatto G, Magrì D, Agostoni P, Parati G.
    Cardiovasc Ther; 2012 Aug 21; 30(4):240-8. PubMed ID: 21883997
    [Abstract] [Full Text] [Related]

  • 34. Beneficial influence of carvedilol on urologic indices in patients with hypertension and benign prostatic hyperplasia: results of a randomized, crossover study.
    Lewandowski J, Sinski M, Symonides B, Korecki J, Rogowski K, Judycki J, Sieczych A, Możeńska O, Gaciong Z.
    Urology; 2013 Sep 21; 82(3):660-5. PubMed ID: 23987161
    [Abstract] [Full Text] [Related]

  • 35. Impact of 6 months of therapy with carvedilol on muscle sympathetic nerve activity in heart failure patients.
    De Matos LD, Gardenghi G, Rondon MU, Soufen HN, Tirone AP, Barretto AC, Brum PC, Middlekauff HR, Negrão CE.
    J Card Fail; 2004 Dec 21; 10(6):496-502. PubMed ID: 15599840
    [Abstract] [Full Text] [Related]

  • 36. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul 15; 92(2):212-8. PubMed ID: 7600653
    [Abstract] [Full Text] [Related]

  • 37. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action.
    Jamal SM, Freedman SB, Thomson A, Carter G, Harris PJ, Kelly DT.
    J Cardiovasc Pharmacol; 1987 Jul 15; 10 Suppl 11():S141-6. PubMed ID: 2454361
    [Abstract] [Full Text] [Related]

  • 38. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A, Azevedo ER, Floras JS, Hollingshead S, Lopaschuk GD, Parker JD.
    Eur J Heart Fail; 2005 Jun 15; 7(4):618-23. PubMed ID: 15921803
    [Abstract] [Full Text] [Related]

  • 39. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
    Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH.
    N Engl J Med; 1996 May 23; 334(21):1349-55. PubMed ID: 8614419
    [Abstract] [Full Text] [Related]

  • 40. Acute effects of a single oral dose of carvedilol on cardiac sympathovagal balance in man.
    Haseroth K, Löffler P, Janson CP, Kropff S, Schmidt BM, Feuring M, Christ M, Wehling M.
    Int J Clin Pharmacol Ther; 2001 Jul 23; 39(7):315-21. PubMed ID: 11471776
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.